R&D Why clinical trials lose a quarter of their patients before ... Data fragmentation creates unnecessary burden on sponsors and the people clinical trials aim to serve.
News Roche breast cancer drug Itovebi turned down by NICE NICE turns down NHS use of Roche's breast cancer drug Itovebi, which the company says reveals a flaw in the appraisal of combination therapies.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
